BackImmunogen Overview

Immunogen Net Income

Profitability analysis for IMGN.

Quarterly Net Income

$30.75M
139.54% YoY

As of Sep 2023

Annual Net Income (TTM)

-$73.07M
63.66% YoY

Trailing 12 months ending Sep 2023

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...